Two recent studies by Pinton and co-workers [45, 46] addressed these key points and revealed groundbreaking insights in the p53/Ca2+ signaling connection for inducing cell death in cancer cells in response to anti-cancer treatments. The gene discussed is TP53; the disease is cancer.